Device Development Plan). 3.3.1 Attached hereto as Schedule B is a plan mutually agreed to by the Parties that sets forth the Development Program activities for the Device (the “Device Development Plan”), including, without limitation: (a) Product Requirements (prepared by Dance in consultation with and accepted by Aerogen), (b) Specifications (prepared by Aerogen in consultation with and approved by Dance),
Appears in 2 contracts
Sources: License Agreement (Dance Biopharm, Inc.), License, Development, Collaboration, and Commercialization Agreement (Dance Biopharm, Inc.)